908 Devices, Inc. (MASS)
| Market Cap | 1.66B |
| Revenue (ttm) | 29.53M |
| Net Income (ttm) | -3.08M |
| Shares Out | 26.19M |
| EPS (ttm) | -0.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 19 |
| Last Price | $64.90 |
| Previous Close | $62.45 |
| Change ($) | 2.45 |
| Change (%) | 3.92% |
| Day's Open | 62.22 |
| Day's Range | 62.40 - 67.44 |
| Day's Volume | 141,563 |
| 52-Week Range | 49.00 - 67.92 |
BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the closing of its upsized ...
908 Devices is a very interesting business with great potential and recent operating momentum. Expectations have risen quite a bit after a big opening day move higher; I still like the long-te...
Shares of 908 Devices Inc. more than doubled on their public debut, as the Massachusetts-based biochemical analysis device company's stock opened 127.6% above the upsized initial public offeri...
Research device maker prices shares at $20 each.
BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the pricing of its upsized ...
908 Devices, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced that it has filed a registration statement on Form S-1 wi...
908 Devices, which provides a suite of mass spectrometry devices for scientific research, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering.
908 Devices, Inc. has filed to go public with an IPO on the NASDAQ.
About MASS
908 Devices develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. It offers handheld and desktop Mass Spec devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is d... [Read more...]
| Industry Medical Devices | IPO Date Dec 18, 2020 |
| CEO Kevin J. Knopp | Employees 96 |
| Stock Exchange NASDAQ | Ticker Symbol MASS |
Financial Performance
In 2019, 908 Devices's revenue was $17.97 million, a decrease of -18.51% compared to the previous year's $22.05 million. Losses were -$13.37 million, 77.5% more than in 2018.
Analyst Forecasts
According to 4 analysts, the average rating for 908 Devices stock is "Strong Buy." The 12-month stock price forecast is 65.00, which is an increase of 0.15% from the latest price.